1. Compared to placebo and azacytidine, the combination of ivosidenib and azacitidine demonstrated significant clinical benefit for IDH1-mutated acute myeloid ...
1. Event-free survival and median overall survival were significantly longer in the combination group 2. Febrile neutropenia and infections occurred ...
![Fluorophores enhance visualization for image-guided surgery [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2015/01/FISH_13_21-350x250.jpg)
1. Whole-genome sequencing for myeloid cancers, compared to standard cytogenic analysis, was able to more effectively risk-stratify cytogenic cases. 2. ...
1. Oral azacytidine also known as CC-486 has been found to improve survival outcomes in patients with acute myeloid leukemia. ...
1. Older age, progressive disease status, diagnosis of acute myeloid leukemia, non-Hodgkin lymphoma, or plasma cell neoplasms, and severe or ...
1. Sorafenib maintenance therapy following allogenic stem cell transplantation in FLT3-ITD acute myeloid leukemia was associated with significantly lower rates ...
